(Total Views: 692)
Posted On: 08/10/2021 8:10:37 PM
Post# of 153832
"With the Brazil trials the only thing I don't like is the reduction to 350mg after the first dose in the severe trial. It's better to have the full power of leronlimab on display if needed then to not have it."
This was puzzling to me as well. LH trial had 8 weeks @ 700 mg without any indication of SAE's as well as the safety history with HIV trials. What safety signal could possibly have arisen to limit the doses? I wonder if it was ANVISA or Biomm who insisted in the limited dosage. I can't imagine that CYDY would structure the dosing this way on their own.
Read More: https://investorshangout.com/post/newpost/60551?replyto=6211211#ixzz73BdatWBr
This was puzzling to me as well. LH trial had 8 weeks @ 700 mg without any indication of SAE's as well as the safety history with HIV trials. What safety signal could possibly have arisen to limit the doses? I wonder if it was ANVISA or Biomm who insisted in the limited dosage. I can't imagine that CYDY would structure the dosing this way on their own.
Read More: https://investorshangout.com/post/newpost/60551?replyto=6211211#ixzz73BdatWBr
(4)
(0)
